home / stock / fwbi / fwbi news

FWBI News and Press, First Wave BioPharma Inc. From 06/13/23

Stock Information
Company Name: First Wave BioPharma Inc.
Stock Symbol: FWBI
Market: NASDAQ
Menu
FWBI FWBI Quote FWBI Short FWBI News FWBI Articles FWBI Message Board
Get FWBI Alerts

News, Short Squeeze, Breakout and More Instantly...
FWBI - CPI Report Live: May Inflation Report Is Out, Here's What It Shows

2023-06-13 08:29:54 ET In this year’s fast-paced financial markets, research reigns supreme for investors seeking to navigate the tides of market fluctuations. Whether you’re trading penny stocks or large-cap equities, understanding the intricacies of the stock market is i...
FWBI - First Wave BioPharma Reaches Enrollment Target for Phase 2 SPAN Adrulipase Clinical Trial in Cystic Fibrosis

Two-thirds of patients have completed study, final patients being dosed Top line data read-out on track for July 2023 BOCA RATON, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company”) (NASDAQ: FWBI), a clinical...

FWBI - IDEX, APRN and CAMP among mid-day movers

2023-06-08 12:49:18 ET Gainers: Airspan Networks Holdings ( MIMO ) +104% . Baosheng Media Group ( BAOS ) +73% . Carvana CVNA +41% . Ideanomics ( IDEX ) +23% . ThermoGenesis Holdings ( THMO ) +23% . Rigetti Computing ( RGTI ) ...

FWBI - First Wave BioPharma CEO James Sapirstein to Present at 2023 BIO International Conference

BOCA RATON, Fla., May 15, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointes...
FWBI - First Wave BioPharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis

Top line data read-out on track for July 2023 BOCA RATON, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company”) (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non...

FWBI - First Wave BioPharma to Participate in EF Hutton Inaugural Global Conference

BOCA RATON, Fla., May 02, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointes...

FWBI - First Wave Biopharma Exceeds 50% Enrollment Target for Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis

Three U.S. clinical trial sites actively screening and enrolling patients Top line data of adrulipase in Cystic Fibrosis patients expected in July 2023 BOCA RATON, Fla., April 25, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company&#x...
FWBI - Liminal, InflaRx top healthcare gainers; Bullfrog, First Wave among losers

2023-04-05 10:07:20 ET Gainers: Liminal BioSciences ( LMNL ) +81% . InflaRx ( IFRX ) +51% . 180 Life Sciences ( ATNF ) +26% . YS Biopharma ( YS ) +22% . Immunic ( IMUX ) +21% . Losers: Bullfrog AI ( BFRG ) -15% .&#...

FWBI - AI, BFLY and CLSD among mid-day movers

2023-04-04 12:51:54 ET Gainers: Cardlytics ( CDLX ) +62% . Assure Holdings ( IONM ) +56% . The NFT Gaming Company ( NFTG ) +42% . Bullfrog AI Holdings ( BFRG ) +32% . Bellerophon Therapeutics ( BLPH ) +27% . Austin Gold ( A...

FWBI - PaxMedica, Avid Bioservices top healthcare gainers; Rapt, Unicycive lead losers' pack

2023-03-14 10:08:44 ET Gainers: PaxMedica ( PXMD ) +36% . Avid Bioservices ( CDMO ) +25% . Amylyx Pharmaceuticals ( AMLX ) +17% . Euda Health ( EUDA ) +17% .  Addex Therapeutics ( ADXN ) +11% . Losers: Rapt Therap...
Previous 10 Next 10